News 2 Nov 2026 Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access
Press releases 29 Oct 2026 DNDi welcomes GHIT Fund’s support for innovative approaches to improve success in Chagas disease drug discovery with Nagasaki University, the University of Dundee, and Eisai
Scientific articles 27 Oct 2026 Strengthening health systems and clinical development capacities through effective partnerships: a case study of DNDi’s collaboration with the Leishmaniasis Research and Treatment Center in Ethiopia (2003–2022) Frontiers in Tropical Diseases
Scientific articles 26 Oct 2026 Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial eClinicalMedicine
Scientific articles 22 Oct 2026 Deconvoluting the mode of action of antileishmanial aminopyrazoles through chemical mutagenesis Nature communications
Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infectious Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
Stories 23 May 2024 Defying the odds: One doctor’s remarkable journey to helping patients with kala-azar
Stories 16 Mar 2023 Cutaneous leishmaniasis: Swiss students develop innovative thermotherapy device for safer treatment of ‘flesh-eating parasite’
Stories 8 Mar 2023 Highlighting gender-based treatment gaps on International Women’s Day: Mary Alamak’s story
Stories 10 Nov 2021 MycetOS: Harnessing the power of open source to develop treatments for a most neglected disease
Stories 29 Oct 2021 Pip Stewart on cutaneous leishmaniasis: ‘It wasn’t just the parasite that got under my skin, it was the injustice of it’
Stories 20 Oct 2021 ‘We are building a generation of scientists who will transform research in Africa’
Stories 30 Jul 2021 ‘A clear demonstration of the capacity in Africa to conduct extremely complex studies’ – Dr John Amuasi on the ANTICOV trial in Ghana
Stories 29 Jul 2021 Recruitment begins in Mozambique for ANTICOV clinical trial of early treatments for COVID-19
